These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 16189258
1. Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC. J Clin Endocrinol Metab; 2005 Dec; 90(12):6370-2. PubMed ID: 16189258 [Abstract] [Full Text] [Related]
2. Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, Pepe J, Clemente G, Tonnarini G, Minisola S. Clin Chem; 2004 Mar; 50(3):626-31. PubMed ID: 14718396 [Abstract] [Full Text] [Related]
3. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B. Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888 [Abstract] [Full Text] [Related]
4. Experience with a third-generation parathyroid hormone assay (BIO-PTH) in the diagnosis of primary hyperparathyroidism in a Brazilian population. Bonanséa TC, Ohe MN, Brandão C, Ferrer CF, Santos LM, Lazaretti-Castro M, Vieira JG. Arch Endocrinol Metab; 2016 Oct; 60(5):420-425. PubMed ID: 27812604 [Abstract] [Full Text] [Related]
6. Comparison of three parathyroid hormone assays. Nisbet JA. Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():429-33. PubMed ID: 3767271 [Abstract] [Full Text] [Related]
7. Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism. Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC. Clin Chem; 2006 Apr; 52(4):757-60. PubMed ID: 16497941 [Abstract] [Full Text] [Related]
8. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. Bergenfelz A, Lindblom P, Lindergård B, Valdemarsson S, Westerdahl J. World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497 [Abstract] [Full Text] [Related]
9. [Intact whole bioactive parathormone: problems arising from comparing different methods]. Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D. G Ital Nefrol; 2002 Apr; 19(4):467-75. PubMed ID: 12369051 [Abstract] [Full Text] [Related]
10. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism. Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC. Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355 [Abstract] [Full Text] [Related]
11. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. Lindall AW, Elting J, Ells J, Roos BA. J Clin Endocrinol Metab; 1983 Nov; 57(5):1007-14. PubMed ID: 6311857 [Abstract] [Full Text] [Related]
12. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease. Herberth J, Fahrleitner-Pammer A, Obermayer-Pietsch B, Krisper P, Holzer H, Malluche HH, Dobnig H. Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653 [Abstract] [Full Text] [Related]
13. Clinical and laboratory evaluation of a two-site immunoradiometric assay for intact parathyroid hormone. Newman DJ, Ashby JP. Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():654-60. PubMed ID: 3254105 [Abstract] [Full Text] [Related]
14. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, Baulieu EE. J Clin Endocrinol Metab; 2001 Jul; 86(7):3086-90. PubMed ID: 11443171 [Abstract] [Full Text] [Related]
15. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism. Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H. J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873 [Abstract] [Full Text] [Related]
16. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism. Nussbaum SR, Potts JT. J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383 [Abstract] [Full Text] [Related]
17. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP, Beckers A. J Clin Endocrinol Metab; 2010 Aug; 95(8):3745-9. PubMed ID: 20519352 [Abstract] [Full Text] [Related]
18. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. Blind E, Schmidt-Gayk H, Scharla S, Flentje D, Fischer S, Göhring U, Hitzler W. J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561 [Abstract] [Full Text] [Related]
19. Measurement of parathyroid hormone. Endres DB, Villanueva R, Sharp CF, Singer FR. Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765 [Abstract] [Full Text] [Related]
20. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM. J Clin Endocrinol Metab; 2006 Oct; 91(10):3826-9. PubMed ID: 16849415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]